Literature DB >> 30236386

Outcomes of Catheter Ablation of Ventricular Tachycardia Based on Etiology in Nonischemic Heart Disease: An International Ventricular Tachycardia Ablation Center Collaborative Study.

Marmar Vaseghi1, Tiffany Y Hu2, Roderick Tung3, Pasquale Vergara4, David S Frankel5, Luigi Di Biase6, Usha B Tedrow7, Jeffrey A Gornbein8, Ricky Yu2, Nilesh Mathuria9, Shiro Nakahara10, Wendy S Tzou11, William H Sauer11, J David Burkhardt12, Venkatakrishna N Tholakanahalli13, Timm-Michael Dickfeld14, J Peter Weiss15, T Jared Bunch15, Madhu Reddy16, David J Callans5, Dhanunjaya R Lakkireddy17, Andrea Natale12, Francis E Marchlinski5, William G Stevenson18, Paolo Della Bella4, Kalyanam Shivkumar2.   

Abstract

OBJECTIVES: This study sought to characterize ventricular tachycardia (VT) ablation outcomes across nonischemic cardiomyopathy (NICM) etiologies and adjust these outcomes by patient-related comorbidities that could explain differences in arrhythmia recurrence rates.
BACKGROUND: Outcomes of catheter ablation of VT in patients with NICM could be related to etiology of NICM.
METHODS: Data from 2,075 patients with structural heart disease referred for catheter ablation of VT from 12 international centers was retrospectively analyzed. Patient characteristics and outcomes were noted for the 6 most common NICM etiologies. Multivariable Cox proportional hazards modeling was used to adjust for potential confounders.
RESULTS: Of 780 NICM patients (57 ± 14 years of age, 18% women, left ventricular ejection fraction 37 ± 13%), underlying prevalence was 66% for dilated idiopathic cardiomyopathy (DICM), 13% for arrhythmogenic right ventricular cardiomyopathy (ARVC), 6% for valvular cardiomyopathy, 6% for myocarditis, 4% for hypertrophic cardiomyopathy, and 3% for sarcoidosis. One-year freedom from VT was 69%, and freedom from VT, heart transplantation, and death was 62%. On unadjusted competing risk analysis, VT ablation in ARVC demonstrated superior VT-free survival (82%) versus DICM (p ≤ 0.01). Valvular cardiomyopathy had the poorest unadjusted VT-free survival, at 47% (p < 0.01). After adjusting for comorbidities, including age, heart failure severity, ejection fraction, prior ablation, and antiarrhythmic medication use, myocarditis, ARVC, and DICM demonstrated similar outcomes, whereas hypertrophic cardiomyopathy, valvular cardiomyopathy, and sarcoidosis had the highest risk of VT recurrence.
CONCLUSIONS: Catheter ablation of VT in NICM is effective. Etiology of NICM is a significant predictor of outcomes, with ARVC, myocarditis, and DICM having similar but superior outcomes to hypertrophic cardiomyopathy, valvular cardiomyopathy, and sarcoidosis, after adjusting for potential covariates.
Copyright © 2018 American College of Cardiology Foundation. All rights reserved.

Entities:  

Keywords:  ablation; arrhythmogenic right ventricular cardiomyopathy; myocarditis; nonischemic; sarcoidosis; valvular; ventricular tachycardia

Mesh:

Year:  2018        PMID: 30236386      PMCID: PMC6242273          DOI: 10.1016/j.jacep.2018.05.007

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN: 2405-500X


  34 in total

1.  Exploring postinfarction reentrant ventricular tachycardia with entrainment mapping.

Authors:  W G Stevenson; P L Friedman; P T Sager; L A Saxon; D Kocovic; T Harada; I Wiener; H Khan
Journal:  J Am Coll Cardiol       Date:  1997-05       Impact factor: 24.094

2.  Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease.

Authors:  Saurabh Kumar; Jorge Romero; Nishaki K Mehta; Akira Fujii; Sunil Kapur; Samuel H Baldinger; Chirag R Barbhaiya; Bruce A Koplan; Roy M John; Laurence M Epstein; Gregory F Michaud; Usha B Tedrow; William G Stevenson
Journal:  Heart Rhythm       Date:  2016-07-05       Impact factor: 6.343

3.  Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation.

Authors:  Saurabh Kumar; Chirag Barbhaiya; Koichi Nagashima; Eue-Keun Choi; Laurence M Epstein; Roy M John; Melanie Maytin; Christine M Albert; Amy L Miller; Bruce A Koplan; Gregory F Michaud; Usha B Tedrow; William G Stevenson
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-12-19

4.  Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study.

Authors:  Borislav Dinov; Lukas Fiedler; Robert Schönbauer; Andreas Bollmann; Sascha Rolf; Christopher Piorkowski; Gerhard Hindricks; Arash Arya
Journal:  Circulation       Date:  2013-11-08       Impact factor: 29.690

5.  Long-term outcomes of catheter ablation of ventricular tachycardia in patients with structural heart disease.

Authors:  Masahiko Goya; Masato Fukunaga; Ken-Ichi Hiroshima; Kentaro Hayashi; Yu Makihara; Michio Nagashima; Yoshimori An; Seiji Ohe; Kennosuke Yamashita; Kenji Ando; Hiroyoshi Yokoi; Masashi Iwabuchi; Kouji Katayama; Tomoaki Ito; Harushi Niu
Journal:  J Arrhythm       Date:  2014-07-03

6.  Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.

Authors:  John L Sapp; George A Wells; Ratika Parkash; William G Stevenson; Louis Blier; Jean-Francois Sarrazin; Bernard Thibault; Lena Rivard; Lorne Gula; Peter Leong-Sit; Vidal Essebag; Pablo B Nery; Stanley K Tung; Jean-Marc Raymond; Laurence D Sterns; George D Veenhuyzen; Jeff S Healey; Damian Redfearn; Jean-Francois Roux; Anthony S L Tang
Journal:  N Engl J Med       Date:  2016-05-05       Impact factor: 91.245

7.  Relation of pace mapping QRS configuration and conduction delay to ventricular tachycardia reentry circuits in human infarct scars.

Authors:  W G Stevenson; P T Sager; P D Natterson; L A Saxon; H R Middlekauff; I Wiener
Journal:  J Am Coll Cardiol       Date:  1995-08       Impact factor: 24.094

8.  Clinical and biophysical evaluation of variable bipolar configurations during radiofrequency ablation for treatment of ventricular arrhythmias.

Authors:  Duy T Nguyen; Wendy S Tzou; Michael Brunnquell; Matthew Zipse; Joseph L Schuller; Lijun Zheng; Ryan A Aleong; William H Sauer
Journal:  Heart Rhythm       Date:  2016-07-14       Impact factor: 6.343

9.  Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.

Authors:  Pasquale Santangeli; Erica S Zado; Gregory E Supple; Haris M Haqqani; Fermin C Garcia; Cory M Tschabrunn; David J Callans; David Lin; Sanjay Dixit; Mathew D Hutchinson; Michael P Riley; Francis E Marchlinski
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-11-06

10.  Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%.

Authors:  Philippe Maury; Francesca Baratto; Katja Zeppenfeld; George Klein; Etienne Delacretaz; Frederic Sacher; Etienne Pruvot; Francois Brigadeau; Anne Rollin; Marius Andronache; Giuseppe Maccabelli; Marcin Gawrysiak; Roman Brenner; Andrei Forclaz; Jürg Schlaepfer; Dominique Lacroix; Alexandre Duparc; Pierre Mondoly; Frederic Bouisset; Marc Delay; Meleze Hocini; Nicolas Derval; Nicolas Sadoul; Isabelle Magnin-Poull; Didier Klug; Michel Haïssaguerre; Pierre Jaïs; Paolo Della Bella; Christian De Chillou
Journal:  Eur Heart J       Date:  2014-02-16       Impact factor: 29.983

View more
  13 in total

1.  Recurrent ventricular tachycardia after cardiac sympathetic denervation: Prolonged cycle length with improved hemodynamic tolerance and ablation outcomes.

Authors:  Justin Hayase; Veronica Dusi; Duc Do; Olujimi A Ajijola; Marmar Vaseghi; Jay M Lee; Jane Yanagawa; Nir Hoftman; Sha'Shonda Revels; Eric F Buch; Houman Khakpour; Osamu Fujimura; Yuliya Krokhaleva; Carlos Macias; Julie Sorg; Jean Gima; Geraldine Pavez; Noel G Boyle; Kalyanam Shivkumar; Jason S Bradfield
Journal:  J Cardiovasc Electrophysiol       Date:  2020-06-30

2.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

3.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Sáenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  Europace       Date:  2019-08-01       Impact factor: 5.214

Review 4.  Update on prevention and treatment of sudden cardiac arrest.

Authors:  Yuliya Krokhaleva; Marmar Vaseghi
Journal:  Trends Cardiovasc Med       Date:  2018-11-06       Impact factor: 6.677

5.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.

Authors:  Jens Cosedis Nielsen; Yenn-Jiang Lin; Marcio Jansen de Oliveira Figueiredo; Alireza Sepehri Shamloo; Alberto Alfie; Serge Boveda; Nikolaos Dagres; Dario Di Toro; Lee L Eckhardt; Kenneth Ellenbogen; Carina Hardy; Takanori Ikeda; Aparna Jaswal; Elizabeth Kaufman; Andrew Krahn; Kengo Kusano; Valentina Kutyifa; Han S Lim; Gregory Y H Lip; Santiago Nava-Townsend; Hui-Nam Pak; Gerardo Rodríguez Diez; William Sauer; Anil Saxena; Jesper Hastrup Svendsen; Diego Vanegas; Marmar Vaseghi; Arthur Wilde; T Jared Bunch; Alfred E Buxton; Gonzalo Calvimontes; Tze-Fan Chao; Lars Eckardt; Heidi Estner; Anne M Gillis; Rodrigo Isa; Josef Kautzner; Philippe Maury; Joshua D Moss; Gi-Byung Nam; Brian Olshansky; Luis Fernando Pava Molano; Mauricio Pimentel; Mukund Prabhu; Wendy S Tzou; Philipp Sommer; Janice Swampillai; Alejandro Vidal; Thomas Deneke; Gerhard Hindricks; Christophe Leclercq
Journal:  Europace       Date:  2020-08-01       Impact factor: 5.214

6.  Patient characteristics, procedure details including catheter devices, and complications of catheter ablation for ventricular tachycardia: a nationwide observational study.

Authors:  Takeshi Kitamura; Mikio Nakajima; Iwanari Kawamura; Hiroyuki Ohbe; Yusuke Sasabuchi; Hiroki Matsui; Kiyohide Fushimi; Seiji Fukamizu; Hideo Yasunaga
Journal:  J Arrhythm       Date:  2020-05-05

7.  Arrhythmic Risk Profile and Outcomes of Patients Undergoing Cardiac Sympathetic Denervation for Recurrent Monomorphic Ventricular Tachycardia After Ablation.

Authors:  Veronica Dusi; Jeffrey Gornbein; Duc H Do; Julie M Sorg; Houman Khakpour; Yuliya Krokhaleva; Olujimi A Ajijola; Carlos Macias; Jason S Bradfield; Eric Buch; Osamu A Fujimura; Noel G Boyle; Jane Yanagawa; Jay M Lee; Kalyanam Shivkumar; Marmar Vaseghi
Journal:  J Am Heart Assoc       Date:  2021-01-14       Impact factor: 5.501

8.  Mechanisms of Arrhythmogenicity in Hypertrophic Cardiomyopathy: Insight From Non-invasive Electrocardiographic Imaging.

Authors:  Erick A Perez-Alday; Kazi T Haq; David M German; Christopher Hamilton; Kyle Johnson; Francis Phan; Nichole M Rogovoy; Katherine Yang; Ashley Wirth; Jason A Thomas; Khidir Dalouk; Cristina Fuss; Maros Ferencik; Stephen Heitner; Larisa G Tereshchenko
Journal:  Front Physiol       Date:  2020-04-24       Impact factor: 4.566

9.  Meta-analysis comparing outcomes of catheter ablation for ventricular arrhythmia in ischemic versus nonischemic cardiomyopathy.

Authors:  Indranill Basu-Ray; Dibbendhu Khanra; Sumit K Shah; Anindya Mukherjee; Sudhanva V Char; Bhavna Jain; T Jared Bunch; Michael Gold; Adedayo A Adeboye; Mohammad Saeed
Journal:  Pacing Clin Electrophysiol       Date:  2020-11-30       Impact factor: 1.976

10.  Bipolar ablation's unique paradigm: Duration and power as respectively distinct primary determinants of transmurality and steam pop formation.

Authors:  Mathews John; Ashley Rook; Allison Post; Alton Mersman; Whitney Allen; Christina Schramm; Mehdi Razavi
Journal:  Heart Rhythm O2       Date:  2020-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.